Evidence map›Paper›PMID 40294010›Full record

ArticlePLoS pathogens2025

EV-D68 cleaves LARP1 and PABPC1 by 3Cpro to redirect host mRNA translation machinery toward its genomic RNA.

Ruyang Tan, Yuling Zhang, Mengqian Huang, Honghua Chen, Zixiang Liu, Zining Wang, Xiaoyan Li, Tao Wang, Zhiyun Wang

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruyang TanSchool of Life Sciences, Tianjin University, Tianjin, China.ORCID 0009-0003-9874-607X
Yuling ZhangSchool of Life Sciences, Tianjin University, Tianjin, China.
Mengqian HuangSchool of Life Sciences, Tianjin University, Tianjin, China.
Honghua ChenSchool of Life Sciences, Tianjin University, Tianjin, China.
Zixiang LiuSchool of Life Sciences, Tianjin University, Tianjin, China.
Zining WangSchool of Life Sciences, Tianjin University, Tianjin, China.
Xiaoyan LiTianjin Centers for Disease Control and Prevention, Tianjin, China.
Tao WangSchool of Life Sciences, Tianjin University, Tianjin, China.ORCID 0000-0003-1490-7407
Zhiyun WangSchool of Environmental Science and Engineering, Tianjin University, Tianjin, China.ORCID 0000-0001-5236-8948

Funding

National Natural Science Foundation of China (NSFC)
6 · The paper itself

Abstract

Enterovirus D68 (EV-D68) is an emerging pathogen associated with severe respiratory diseases and neurological complications, such as acute flaccid myelitis. EV-D68 has developed sophisticated mechanisms to hijack host translation machinery, facilitating its replication and impairing host mRNA translation. In this study, we demonstrate that EV-D68 cleaves La-related protein 1 (LARP1) and poly(A)-binding protein cytoplasmic 1 (PABPC1) through its proteases 3Cpro and 2Apro. Our results indicate that overexpressing LARP1 and PABPC1 significantly inhibits EV-D68 replication and reduces the virus-mediated suppression of host translation. While both LARP1 and PABPC1 regulate translation, they exert antiviral effects through distinct mechanisms. We found that LARP1 interacts with the 5'UTR of EV-D68 RNA through its LAM domain, and this interaction is crucial for its antiviral function. LARP1 translation modulation is also influenced by the mTOR and CDK1 signaling pathways. Viral infection inhibits mTOR and CDK1 phosphorylation, which enhances LARP1's binding to viral RNA and inhibits viral translation. To counteract this inhibition, EV-D68 cleaves LARP1 through 3Cpro, thereby promoting efficient viral translation. We also investigated other enteroviruses, such as EV-A71 and CV-A16, which similarly target LARP1 and PABPC1, indicating a conserved mechanism across enteroviruses. Our findings offer new insights into how EV-D68 manipulates host translation and highlight the potential of targeting LARP1 and PABPC1 for antiviral interventions.

Indexed as

AutoantigensEnterovirus D, HumanEnterovirus InfectionsPoly(A)-Binding Protein IProtein BiosynthesisRibonucleoproteinsRNA, MessengerRNA, ViralViral ProteinsHEK293 CellsHost-Pathogen InteractionsHumansRNA, Small CytoplasmicSS-A AntigenSS-B AntigenVirus ReplicationAutoantigensPoly(A)-Binding Protein IRibonucleoproteinsRNA, MessengerRNA, Small CytoplasmicRNA, ViralRO60 protein, humanSS-A AntigenSS-B AntigenViral Proteins

Identifiers

PMID40294010
PMCPMC12036898

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.